Singular Bio
San Francisco
About Singular Bio
Singular Bio's technology provides single molecule analysis of a patient's DNA, giving exquisite sensitivity for detecting many common conditions. The company's mission is to expand access to fundamental healthcare information by making advanced genetic tests available to everyone.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $6.6M
- Funding stage: M&A
- Last round: Series Unknown (Jan 2019)
- Website: singularbio.com
Industries & Categories
Biotechnology, Health Care, Information Technology
Social Profiles
Canonical: https://fsome.com/organization/singular-bio-15937 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.